Viewing Study NCT03162094


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-02-25 @ 8:18 PM
Study NCT ID: NCT03162094
Status: UNKNOWN
Last Update Posted: 2018-10-01
First Post: 2017-04-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
Sponsor: Avizorex Pharma, S.L.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module